Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Detecting improvements in dyspnea in COPD using a three-minute constant rate shuttle walking protocol.

Sava F, Perrault H, Brouillard C, Darauay C, Hamilton A, Bourbeau J, Maltais F.

COPD. 2012 Aug;9(4):395-400. doi: 10.3109/15412555.2012.674164. Epub 2012 Apr 18.

PMID:
22509905
2.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
3.

Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.

Diba C, King GG, Berend N, Salome CM.

Respir Med. 2011 Sep;105(9):1345-51. doi: 10.1016/j.rmed.2011.03.013. Epub 2011 Apr 8.

4.

Walking exercise response to bronchodilation in mild COPD: a randomized trial.

Gagnon P, Saey D, Provencher S, Milot J, Bourbeau J, Tan WC, Martel S, Maltais F.

Respir Med. 2012 Dec;106(12):1695-705. doi: 10.1016/j.rmed.2012.08.021. Epub 2012 Sep 20.

5.

Locus of symptom limitation and exercise response to bronchodilation in chronic obstructive pulmonary disease.

Deschênes D, Pepin V, Saey D, LeBlanc P, Maltais F.

J Cardiopulm Rehabil Prev. 2008 May-Jun;28(3):208-14. doi: 10.1097/01.HCR.0000320074.73846.3b.

PMID:
18496322
6.

Paced-walk and step tests to assess exertional dyspnea in COPD.

Perrault H, Baril J, Henophy S, Rycroft A, Bourbeau J, Maltais F.

COPD. 2009 Oct;6(5):330-9.

PMID:
19863362
7.

Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study.

Wadbo M, Löfdahl CG, Larsson K, Skoogh BE, Tornling G, Arweström E, Bengtsson T, Ström K; Swedish Society of Respiratory Medicine..

Eur Respir J. 2002 Nov;20(5):1138-46.

8.

Six-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary disease.

Pepin V, Brodeur J, Lacasse Y, Milot J, Leblanc P, Whittom F, Maltais F.

Thorax. 2007 Apr;62(4):291-8. Epub 2006 Nov 10.

9.

Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease.

Pepin V, Saey D, Whittom F, LeBlanc P, Maltais F.

Am J Respir Crit Care Med. 2005 Dec 15;172(12):1517-22. Epub 2005 Sep 15.

PMID:
16166613
10.

Responsiveness of continuous ratings of dyspnea during exercise in patients with COPD.

Mahler DA, Fierro-Carrion G, Mejia-Alfaro R, Ward J, Baird JC.

Med Sci Sports Exerc. 2005 Apr;37(4):529-35.

PMID:
15809548
11.

Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.

O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, Ofir D.

Thorax. 2009 Mar;64(3):216-23. doi: 10.1136/thx.2008.103598. Epub 2008 Dec 3.

PMID:
19052054
12.

Endurance shuttle walking test: responsiveness to salmeterol in COPD.

Brouillard C, Pepin V, Milot J, Lacasse Y, Maltais F.

Eur Respir J. 2008 Mar;31(3):579-84. Epub 2007 Dec 5.

13.

[Effect of ipratropium bromide on lung dynamic hyperinflation in patients with chronic obstructive lung disease].

Jorquera J, Díaz O, Lisboa C.

Rev Med Chil. 2003 Jun;131(6):605-12. Spanish.

PMID:
12942587
14.

Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease.

Jensen D, Alsuhail A, Viola R, Dudgeon DJ, Webb KA, O'Donnell DE.

J Pain Symptom Manage. 2012 Apr;43(4):706-19. doi: 10.1016/j.jpainsymman.2011.05.007. Epub 2011 Dec 14.

PMID:
22168961
15.

A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.

Donohue JF, Kalberg C, Emmett A, Merchant K, Knobil K.

Treat Respir Med. 2004;3(3):173-81.

PMID:
15219176
16.

Efficacy of nebulized flunisolide combined with salbutamol and ipratropium bromide in stable patients with moderate-to-severe chronic obstructive pulmonary disease.

Paggiaro PL, Vagaggini B, Di Franco A, Zingoni M, Fano M, Biraghi M.

Respiration. 2006;73(5):603-9. Epub 2005 Nov 15.

PMID:
16293958
17.

The effect of bronchodilators and oxygen alone and in combination on self-paced exercise performance in stable COPD.

Cukier A, Ferreira CA, Stelmach R, Ribeiro M, Cortopassi F, Calverley PM.

Respir Med. 2007 Apr;101(4):746-53. Epub 2006 Sep 26.

18.

[Dyspnea in COPD: relation to the MRC scale with dyspnea induced by walking and cardiopulmonary stress testing].

Gallego MC, Samaniego J, Alonso J, Sánchez A, Carrizo S, Marín JM.

Arch Bronconeumol. 2002 Mar;38(3):112-6. Spanish.

19.

Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD.

Corda L, Bertella E, La Piana GE, Boni E, Redolfi S, Tantucci C.

Respiration. 2008;76(1):61-8. doi: 10.1159/000119718. Epub 2008 Mar 4.

PMID:
18319586
20.

[Lung function and exercise tolerance after treatment with salmeterol or ipratropium bromide in chronic obstructive pulmonary disease].

Grzanka A, Pitsch T, Krzywiecki A, Rogala B.

Pol Merkur Lekarski. 2004 Sep;17(99):208-11. Polish.

PMID:
15628041

Supplemental Content

Support Center